These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36694770)

  • 1. Prevalence of Lipohypertrophy and its Associations in Insulin-Treated Diabetic Patients.
    Nawaz A; Hasham MA; Shireen M; Iftikhar M
    Pak J Med Sci; 2023; 39(1):209-213. PubMed ID: 36694770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipohypertrophy prevalence and its associated risk factors in insulin-treated patients with type 2 diabetes in North Borneo, Malaysia.
    Nain RA; Thomas DC
    Belitung Nurs J; 2022; 8(6):521-528. PubMed ID: 37554235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of Lipohypertrophy and Associated Risk Factors in Young Patients with Type 1 Diabetes: A Cross-Sectional Study.
    Al Hayek AA; Robert AA; Braham RB; Al Dawish MA
    Diabetes Ther; 2016 Jun; 7(2):259-67. PubMed ID: 26979975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Errors in insulin treatment management and risk of lipohypertrophy.
    Pozzuoli GM; Laudato M; Barone M; Crisci F; Pozzuoli B
    Acta Diabetol; 2018 Jan; 55(1):67-73. PubMed ID: 29098390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes.
    Blanco M; Hernández MT; Strauss KW; Amaya M
    Diabetes Metab; 2013 Oct; 39(5):445-53. PubMed ID: 23886784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and associated factors of lipohypertrophy in insulin-injected patients with diabetes in selected primary care clinics in Peninsular Malaysian: A cross-sectional study.
    Hawa A; Teng CL; Devaraj NK; Saadatun A; Rawaida AL; Chong FY; Syamimi Y; Danial D; Lim PW
    Malays Fam Physician; 2023; 18():37. PubMed ID: 37449277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010.
    Ji J; Lou Q
    Curr Med Res Opin; 2014 Jun; 30(6):1087-93. PubMed ID: 24552616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of lipohypertrophy and its associated factors among Saudi patients with type 2 diabetes mellitus.
    AlJaber AN; Sales I; Almigbal TH; Wajid S; Batais MA
    J Taibah Univ Med Sci; 2020 Jun; 15(3):224-231. PubMed ID: 32647518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Lipohypertrophy in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion.
    Barlas T; Yalcin MM; Coskun M; Demirel D; Altinova AE; Toruner FB; Karakoc MA; Yetkin I; Akturk M
    Endocr Pract; 2023 Feb; 29(2):119-126. PubMed ID: 36423861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy.
    Wang K; Zhang S; Liu C; Chen Y
    Therapie; 2021; 76(6):617-628. PubMed ID: 33958198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications of Lipohypertrophy Among People with Type 1 Diabetes in India.
    Gupta SS; Gupta KS; Gathe SS; Bamrah P; Gupta SS
    Diabetes Technol Ther; 2018 Jul; 20(7):483-491. PubMed ID: 29932731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of lipohypertrophy and associated risk factors in insulin-treated patients with type 2 diabetes mellitus.
    Al Ajlouni M; Abujbara M; Batieha A; Ajlouni K
    Int J Endocrinol Metab; 2015 Apr; 13(2):e20776. PubMed ID: 25926852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipohypertrophy in China: Prevalence, Risk Factors, Insulin Consumption, and Clinical Impact.
    Ji L; Sun Z; Li Q; Qin G; Wei Z; Liu J; Chandran AB; Hirsch LJ
    Diabetes Technol Ther; 2017 Jan; 19(1):61-67. PubMed ID: 28099050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worldwide Injection Technique Questionnaire Study: Injecting Complications and the Role of the Professional.
    Frid AH; Hirsch LJ; Menchior AR; Morel DR; Strauss KW
    Mayo Clin Proc; 2016 Sep; 91(9):1224-30. PubMed ID: 27594186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why Do So Many People with Type 2 Diabetes Who Take Insulin Have Lipohypertrophy? Fate or Educational Deficiencies?
    Gentile S; Guarino G; Della Corte T; Marino G; Satta E; Pasquarella M; Romano C; Alfarone C; Giordano L; Loiacono F; Capece M; Lamberti R; Strollo F;
    Diabetes Ther; 2023 Jan; 14(1):179-191. PubMed ID: 36472805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of insulin-induced lipodystrophy in children, adolescents, and young adults with type 1 diabetes mellitus using recombinant human insulin: a cross-sectional study.
    Singha A; Bhattacharjee R; Dalal BS; Biswas D; Choudhuri S; Chowdhury S
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):503-508. PubMed ID: 33662195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipohypertrophy in Individuals with Type 2 Diabetes: Prevalence and Risk Factors.
    Sürücü HA; OKur Arslan H
    J Caring Sci; 2018 Jun; 7(2):67-74. PubMed ID: 29977876
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin-Related Lipohypertrophy: Lipogenic Action or Tissue Trauma?
    Barola A; Tiwari P; Bhansali A; Grover S; Dayal D
    Front Endocrinol (Lausanne); 2018; 9():638. PubMed ID: 30425682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach.
    Gentile S; Strollo F; Satta E; Della Corte T; Romano C; Guarino G;
    Diabetes Ther; 2019 Aug; 10(4):1423-1433. PubMed ID: 31222593
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.